Pharma market sees 6.1% growth in October despite subdued volumes
dermatology, even as sales volume dipped year-on-year, data from market research firm Pharmarack showed.
«Majority of the therapies are showing a positive growth, though unit growth continues to be a challenge for the current month (November),» said Sheetal Sapale, vice president-commercial, Pharmarack.
The growth is driven price and new introductions while most therapies have seen a drop in volumes, she said.
Amongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The anti-hypertensives, which account for almost 50% of the cardiac segment, is experiencing stagnated volume growth. Lipid-lowering drugs and platelet aggregation inhibitors have shown a relatively higher growth to help boost the cardiac segment.
In the anti-infective segment, antibacterials-which contribute to almost 87%-have brought down the volumes. Antifungals, on the other hand, have grown in volumes.
Artificial Intelligence(AI)
Java Programming with ChatGPT: Learn using Generative AI
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Master in Python Language Quickly Using the ChatGPT Open AI
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Mastering C++ Fundamentals with Generative AI: A Hands-On
By — Metla Sudha Sekhar, IT Specialist and Developer
Office Productivity
Zero to Hero in Microsoft Excel: Complete Excel guide 2024
By — Metla Sudha Sekhar, IT Specialist and Developer
Finance
A2Z Of Money
By —
